Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

Authors

  • Paolo Zaurito Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Unit of Urology, Division of Oncology, IRCCS Ospedale San Raffaele, Milan, Italy
  • Hans Garmo Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
  • Rolf Gedeborg Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
  • Mats Ahlberg Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
  • Andri Wilberg Orrason Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
  • Johan Styrke Department of Surgical and Perioperative Sciences, Urology and Andrology, Faculty of Medicine, Umeå University, Umåe, Sweden
  • David Robinson Department of Urology, Ryhov Hospital, Jönköping, Sweden
  • Pär Stattin Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
  • Marcus Westerberg Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

DOI:

https://doi.org/10.2340/sju.v60.43172

Keywords:

Prostate cancer, Epidemiology, COVID-19, Magnetic Resonance, Sweden

Abstract

N/A

Downloads

Download data is not yet available.

References

Mostafavi ZadehSM, Tajik F, Gheytanchi E, Kiani J, Ghods R, Madjd Z. COVID-19 pandemic impact on screening and diagnosis of prostate cancer: a systematic review. BMJ Support Palliat Care. 2023; 14(e2): e1594-e1603 https://doi.org/10.1136/spcare-2023-004310 DOI: https://doi.org/10.1136/spcare-2023-004310

Kaufman HW, Chen Z, Niles J, Fesko Y. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open. 2020;3(8):e2017267. https://doi.org/10.1001/jamanetworkopen.2020.17267 DOI: https://doi.org/10.1001/jamanetworkopen.2020.17267

Fallara G, Sandin F, Styrke J, et al. Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic. Scand J Urol. 2021;55(3):184–191. https://doi.org/10.1080/21681805.2021.1910341 DOI: https://doi.org/10.1080/21681805.2021.1910341

Robinson D, Abdulkareem R, Nasrollah D, et al. Frequency of biopsy and tumor grade before vs after introduction of prostate magnetic resonance imaging. JAMA Netw Open. 2023;6(8):e2330233. https://doi.org/10.1001/jamanetworkopen.2023.30233 DOI: https://doi.org/10.1001/jamanetworkopen.2023.30233

Stranne J. 2023/2024 update of the national prostate cancer guidelines in Sweden. Scand J Urol. 2024;59:210–211. https://doi.org/10.2340/sju.v59.42656 DOI: https://doi.org/10.2340/sju.v59.42656

Stattin P. How to improve cancer care by use of guidelines and quality registers. Scand J Urol. 2024;59:190–192. https://doi.org/10.2340/sju.v59.42272 DOI: https://doi.org/10.2340/sju.v59.42272

Statistics Sweden. Population by age and sex. Year 2007–2023 [Internet]. 2024 [cited 30-09-2024]. Available from: https://www.statistikdatabasen.scb.se/pxweb/en/ssd/START__BE__BE0101__BE0101A/BefolkningR1860N/

Howlader N, Chen HS, Noone AM, et al. Impact of COVID-19 on 2021 cancer incidence rates and potential rebound from 2020 decline. J Natl Cancer Inst. 2024;117(3):507–510 https://doi.org/10.1093/jnci/djae180 DOI: https://doi.org/10.1093/jnci/djae180

Ward ZJ, Walbaum M, Walbaum B, et al. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis. Lancet Oncol. 2021;22(10):1427–1437. https://doi.org/10.1016/S1470-2045(21)00426-5 DOI: https://doi.org/10.1016/S1470-2045(21)00426-5

Desai MM, Cacciamani GE, Gill K, Zhang J, Liu L, Abreu A, et al. Trends in incidence of metastatic prostate cancer in the US. JAMA Netw Open. 2022;5(3):e222246. https://doi.org/10.1001/jamanetworkopen.2022.2246 DOI: https://doi.org/10.1001/jamanetworkopen.2022.2246

Downloads

Published

2025-05-20

How to Cite

Zaurito, P., Garmo, H., Gedeborg, R., Ahlberg, M., Orrason, A. W., Styrke, J., … Westerberg, M. (2025). Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study. Scandinavian Journal of Urology, 60, 93–96. https://doi.org/10.2340/sju.v60.43172

Issue

Vol. 60 (2025)

Section

Publications

License

Copyright (c) 2025 Paolo Zaurito, Hans Garmo, Rolf Gedeborg, Mats Ahlberg, Andri Wilberg Orrason, Johan Styrke, David Robinson, Pär Stattin, Marcus Westerberg

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY license, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work. 

Crossref
Scopus
Google Scholar
Europe PMC